The global human rabies vaccine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The rabies vaccine is administered to prevent rabies. There are a number of such vaccines available found to be both safe and effective. They can be used to prevent rabies before, and for a period after exposure to the rabies virus, commonly caused by a dog bite or a bat bite. The major factors attributed to the market growth include the growing number of mortalities as a result of rabies coupled with the increasing number of unvaccinated stray dogs in less economically developed development countries. Apart from the stray dogs, the rising number of pets coupled with the poor pet management services and their low immunization rates are also estimated to spur the growth of the global human rabies vaccines market. 

As per the World Health Organization (WHO), around 99% of rabies cases reported in 2015 were from domestic dogs. Other animals leading to rabies infection can be wild dogs, bats, foxes, raccoons, cats, and skunks. Contact with saliva, bites, and scratches by these animals are supposed to be the major causes of rabies infection. Most of the rabies-related mortalities in the US are caused by bats. Low economic and rural regions have high number of rabies cases. Over 40% of patients suffering from rabies are children under 15 years of age.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Product Type

o By Vaccination Type

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  Zoetis Inc., Sanofi S.A., and Merck & Co., Inc., among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Human Rabies Vaccine Market Report by Segment

By Product Type 

• Vero Cell

• Baby Hamster Kidney (BHK)

• Chick Embryo Cell

• Human Diploid Cells

• Others

By Vaccination Type

• Pre-Exposure Vaccination (PEV) 

• Post-Exposure Prophylaxis (PEP)

Global Human Rabies Vaccine Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa